Schedule 13G ownership disclosure
SELLAS Life Sciences Group Inc
Common Stock, par value $0.0001 per share · CUSIP: 81642T209
Event date: 2025-12-31
- Filing-level shares
- 6,514,658.00
- Percent of class
- 3.7%
- Highbridge Capital Management, LLC
Shares: 6,514,658.00 · Class: 3.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-26-000615
- Form type
- SCHEDULE 13G/A
- Filer
- HIGHBRIDGE CAPITAL MANAGEMENT LLC
- CIK
- CIK 919185
- Filed
- Jan 30, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership